Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression
L. C. Foerster, O. Kaya, V. Wust…·A. Martin-Villalba
This study identifies SFRP1 as a therapeutic target for glioblastoma by revealing its role in reprogramming tumor methylomes and improving survival in mouse models.